Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression
- 1 September 2006
- journal article
- clinical trial
- Published by Elsevier in American Journal of Geriatric Psychiatry
- Vol. 14 (9) , 796-802
- https://doi.org/10.1097/01.jgp.0000204328.50105.b3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- CYP2D6 genotype and venlafaxine‐XR concentrations in depressed elderlyInternational Journal of Geriatric Psychiatry, 2006
- Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopramInternational Journal of Geriatric Psychiatry, 2004
- Probing the Safety of Medications in the Frail ElderlyThe Journal of Clinical Psychiatry, 2003
- Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithmInternational Journal of Geriatric Psychiatry, 2001
- Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline‐ and methoxamine‐evoked constriction of the dorsal hand veinBritish Journal of Clinical Pharmacology, 1999
- Effects of Venlafaxine on Blood PressureThe Journal of Clinical Psychiatry, 1998
- Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating ScalePsychiatry Research, 1992
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960